These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 22359292)

  • 21. Promoter hypermethylation of multiple genes in carcinoma of the uterine cervix.
    Dong SM; Kim HS; Rha SH; Sidransky D
    Clin Cancer Res; 2001 Jul; 7(7):1982-6. PubMed ID: 11448914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypermethylation of tumor suppressor genes in cancer.
    Herman JG
    Semin Cancer Biol; 1999 Oct; 9(5):359-67. PubMed ID: 10547344
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor cell colony formation.
    Seng TJ; Low JS; Li H; Cui Y; Goh HK; Wong ML; Srivastava G; Sidransky D; Califano J; Steenbergen RD; Rha SY; Tan J; Hsieh WS; Ambinder RF; Lin X; Chan AT; Tao Q
    Oncogene; 2007 Feb; 26(6):934-44. PubMed ID: 16862168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of ADCYAP1, adenylate cyclase activating polypeptide 1, as a methylation biomarker for the early detection of cervical cancer.
    Jung S; Yi L; Jeong D; Kim J; An S; Oh TJ; Kim CH; Kim CJ; Yang Y; Kim KI; Lim JS; Lee MS
    Oncol Rep; 2011 Jan; 25(1):245-52. PubMed ID: 21109983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epigenetic gene regulation in cancer.
    Ballestar E; Esteller M
    Adv Genet; 2008; 61():247-67. PubMed ID: 18282509
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
    Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
    J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Epigenome and cancer: new possibilities of cancer prevention and therapy?].
    Paluszczak J; Baer-Dubowska W
    Postepy Biochem; 2005; 51(3):244-50. PubMed ID: 16381168
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA methylation changes in prostate cancer.
    Goering W; Kloth M; Schulz WA
    Methods Mol Biol; 2012; 863():47-66. PubMed ID: 22359287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High human papillomavirus oncogene mRNA expression and not viral DNA load is associated with poor prognosis in cervical cancer patients.
    de Boer MA; Jordanova ES; Kenter GG; Peters AA; Corver WE; Trimbos JB; Fleuren GJ
    Clin Cancer Res; 2007 Jan; 13(1):132-8. PubMed ID: 17200347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Analysis on the expression of human papillomavirus type 16 E2 and E6 oncogenes and disruption of E2 in cervical cancer].
    Wang JT; Ding L; Gao ES; Cheng YY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Oct; 28(10):968-71. PubMed ID: 18399141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epigenetic alterations in gastric carcinogenesis.
    Choi IS; Wu TT
    Cell Res; 2005 Apr; 15(4):247-54. PubMed ID: 15857579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells.
    Sima N; Wang S; Wang W; Kong D; Xu Q; Tian X; Luo A; Zhou J; Xu G; Meng L; Lu Y; Ma D
    Gynecol Oncol; 2007 Aug; 106(2):299-304. PubMed ID: 17586029
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inactivation of RAS association domain family 1A gene in cervical carcinomas and the role of human papillomavirus infection.
    Kuzmin I; Liu L; Dammann R; Geil L; Stanbridge EJ; Wilczynski SP; Lerman MI; Pfeifer GP
    Cancer Res; 2003 Apr; 63(8):1888-93. PubMed ID: 12702579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p53-independent growth regulation of cervical cancer cells by the papillomavirus E6 oncogene.
    Spitkovsky D; Aengeneyndt F; Braspenning J; von Knebel Doeberitz M
    Oncogene; 1996 Sep; 13(5):1027-35. PubMed ID: 8806692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients.
    Dulaimi E; Hillinck J; Ibanez de Caceres I; Al-Saleem T; Cairns P
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6189-93. PubMed ID: 15448006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epigenetic modifications and human pathologies: cancer and CVD.
    Duthie SJ
    Proc Nutr Soc; 2011 Feb; 70(1):47-56. PubMed ID: 21067630
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenetic silencing of the WNT antagonist DICKKOPF-1 in cervical cancer cell lines.
    Lee J; Yoon YS; Chung JH
    Gynecol Oncol; 2008 May; 109(2):270-4. PubMed ID: 18377964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epigenetic Alterations in Human Papillomavirus-Associated Cancers.
    Soto D; Song C; McLaughlin-Drubin ME
    Viruses; 2017 Sep; 9(9):. PubMed ID: 28862667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Silencing of gene expression by targeted DNA methylation: concepts and approaches.
    Jurkowska RZ; Jeltsch A
    Methods Mol Biol; 2010; 649():149-61. PubMed ID: 20680833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A promising hypothesis of c-KIT methylation/ expression paradox in c-KIT (+) squamous cell carcinoma of uterine cervix ----- CTCF transcriptional repressor regulates c-KIT proto-oncogene expression.
    Chang SW; Chao WR; Ruan A; Wang PH; Lin JC; Han CP
    Diagn Pathol; 2015 Nov; 10():207. PubMed ID: 26607501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.